David Toung
Stock Analyst at Argus Research
(3.37)
# 1,006
Out of 5,090 analysts
129
Total ratings
65%
Success rate
9.94%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $61.68 | +10.25% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $572.77 | +6.50% | 8 | Oct 29, 2025 | |
| HOLX Hologic | Maintains: Buy | $80 → $90 | $74.97 | +20.05% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $101.36 | +13.46% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $257.85 | +9.36% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $330.75 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $38.95 | +33.50% | 1 | Jul 1, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $330.91 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $13.23 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $226.08 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $198.83 | -37.13% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $184.31 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $329.89 | +3.06% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $808.62 | -17.14% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $94.28 | +59.10% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,010.31 | -16.86% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $85.46 | +28.72% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $258.39 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.03 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $364.02 | -14.84% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $486.70 | -36.31% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $575.34 | -44.38% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $125.08 | +7.93% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $121.22 | -38.13% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $52.15 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $99.72 | +10.31% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.59 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $90.18 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $132.16 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $201.93 | -23.24% | 4 | Mar 27, 2020 |
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $61.68
Upside: +10.25%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $572.77
Upside: +6.50%
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $74.97
Upside: +20.05%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $101.36
Upside: +13.46%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $257.85
Upside: +9.36%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $330.75
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $38.95
Upside: +33.50%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $330.91
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $13.23
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $226.08
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $198.83
Upside: -37.13%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $184.31
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $329.89
Upside: +3.06%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $808.62
Upside: -17.14%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $94.28
Upside: +59.10%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,010.31
Upside: -16.86%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $85.46
Upside: +28.72%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $258.39
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $26.03
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $364.02
Upside: -14.84%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $486.70
Upside: -36.31%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $575.34
Upside: -44.38%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $125.08
Upside: +7.93%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $121.22
Upside: -38.13%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $52.15
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $99.72
Upside: +10.31%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.59
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $90.18
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $132.16
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $201.93
Upside: -23.24%